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Background: Cosmos caudatus is a local plant which has antioxidant properties and contains high calcium. It is also
reported to be able to strengthen the bone. This report is an extension to previously published article in Evidence
Based Complementary and Alternative Medicine (doi:10.1155/2012/817814). In this study, we determined the
effectiveness of C. caudatus as an alternative treatment for osteoporosis due to post-menopause by looking
at the dynamic and cellular paramaters of bone histomorphometry.
Methods: Forty female Wistar rats were divided into four groups i.e. sham operated, ovariectomized,
ovariectomized treated with calcium 1% ad libitum and ovariectomized force-fed with 500 mg/kg C. caudatus
extract. Treatment was given six days a week for eight weeks.
Results: Dynamic and cellular histomorphometry parameters were measured. C. caudatus increased double-labeled
surface (dLS/BS), mineral appositional rate (MAR), osteoid volume (OV/BV) and osteoblast surface (Ob.S/BS). C.
caudatus also gave better results compared to calcium 1% in the osteoid volume (OV/BV) parameter.
Conclusions: C. caudatus at the 500 mg/kg dose may be an alternative treatment in restoring bone damage that
may occur in post-menopausal women.
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This paper reported the findings which were an exten-
sion to an article recently published [1].
Low bone mass and deterioration of bone tissue
microarchitectural which are observed in osteoporosis
may eventually lead to increase bone fragility and ten-
dency to fracture [2,3]. Osteoporosis has many negative
impacts on public health by increasing death rates and
economic costs due to the impact of the fracture [2].
Increasing age is a major risk for osteoporosis and frac-
tures [4].
To date, there are several treatments available to treat
osteoporosis such as bisphosphonates, calcitonin, estro-
gen and/or hormone therapy, selective estrogen receptor
modulator, anabolic agents and others [5]. However,* Correspondence: azlina@medic.ukm.my
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distribution, and reproduction in any mediumthere are many studies reporting that these treatments
have side effects such as estrogen treatment can pose
risk of breast cancer [6], ovarian and endometrial cancer
[7] to the osteoporosis patients even though it can re-
duce the fracture of hip, vertebrae and other bones [8].
Natural products have been proven to affect bone metab-
olism by involving a complex balance between deposition,
mineralization and resorption of bone matrix [9]. Natural
substances that were often studied and were observed to
have osteoprotective effects were phytoestrogens such as
ferutinin [10], genistein [11] and 8-prenylnaringenin [12].
Cosmos caudatus or better known among locals as
ulam raja is a popular herb in Malaysia [13]. Methanol
extract of C. caudatus was found to have antioxidant
activity [14,15]. In addition, C. caudatus was also found
to have antifungal activity [16] and can stimulate bone
formation [17]. In analogy with other vegetal substances
already demonstrated to mime osteoprotective functions
as described above, C. caudatus was considered to betral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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determine the effects of C. caudatus on dynamic and
cellular bone histomorphometry of ovariectomized rats




This study utilized thirty-two young adult (3 months)
female Wistar rats, which were obtained from the La-
boratory Animal Resource Unit, Faculty of Medicine,
Universiti Kebangsaan Malaysia. The rats, weighing
190 g-260 g, were randomly assigned to four groups
with eight rats in each group. Group 1 was sham oper-
ated (Sham) while the second group was ovariectomized
control group (OVX). The third and fourth groups were
ovariectomized and treated with calcium 1% (Ca) ad
libitum and force-fed with 500 mg/kg C. caudatus ex-
tract (CC) respectively. The ovariectomy and sham oper-
ation protocol was carried out as previously described
[18]. Rats were left recuperating for 1 week before com-
mencing the treatment. Treatment was given six days a
week for eight weeks. All rats were injected with two
doses of calcein nine days and two days before sacrificed.
The study was approved by the Universiti Kebangsaan
Malaysia Animal Ethics Committee with the approval
code of PP/FAR/2008/NORAZLINA/12-AUGUST/225-
SEPT-2008-AUG-2009.
Diet, Cosmos caudatus and calcium 1%
All rats received normal rat chow obtained from Gold
Coin, Malaysia. Water extraction method was used to
obtain 500 g/300 ml concentration of C. caudatus aque-
ous extract. Extraction was carried out by School of
Chemical Sciences & Food Technology, Faculty of Sci-
ence and Technology, Universiti Kebangsaan Malaysia as
previously described [19]. The 500 mg/kg dose was
prepared by mixing C. caudatus with deionized water in
ratio 3:7. Calcium 1% solution was prepared by mixing
1 g of hemicalcium lactic acid (Sigma Chemical CO.,
USA) with 100 ml deionized water.
Bone histomorphometry
After 8 weeks of treatment, rats were sacrificed via
euthanasia with diethyl ether. The left femora were re-
moved and the distal parts were fixed in 70% ethanol.
Cellular parameters measured were osteoid volume
(OV/BS, osteoid volume over bone surface), osteoid sur-
face (OS/BS, osteoid surface over bone surface), osteo-
clast surface (Oc.S/BS, osteoclast surface over bone
surface), osteoblast surface (Ob.S/BS, osteoblast surface
over bone surface) and eroded surface (ES/BS, eroded
surface over bone surface). Bone samples were de-
calcified according to the method described by Hermiziet al. [20]. In addition, undecalcified bone samples were
used to measure dynamic parameters i.e. single labeled
surface (sLS/BS, single labeled surface over bone sur-
face), double-labeled surface (dLS/BS, double-labeled
surface over bone surface), mineralized surface (MS/BS,
mineralized surface over bone surface), mineral appos-
itional rate (MAR), and bone formation rate (BFR/BS,
bone formation rate over bone surface). Preparation of
bone samples and measurement techniques were carried
out as previously described [20].
Statistical analysis
All data were subjected to normality test using the Kol-
mogorov test. For normally distributed data, the statis-
tical test used was analysis of variance, followed by
Tukey’s honestly significance difference test. While non-
normally distributed data were analysed using Mann–
Whitney and Kruskal Wallis tests. Data analysis was
performed using Statistical Package for Social Sciences
(18.0.1; SPSS, Inc., Chicago, IL) software. Results were
expressed as mean ± standard error of the mean (SEM).
Results
Figure 1 shows the photomictorographs of the trabecular
bone of the distal part of femurs analysed using fluores-
cence microscope. Calcein acts as a fluorescent marker
which labels the bone surface thus the double-labeled
surface (dLS) and single-labeled surface (sLS) parameters
may be determined. From the photos, it was observed
that the OVX group had more sLS than dLS while the
Ca and CC groups had more dLS than sLS.
Table 1 shows the dynamic bone histomorphometric
results. The Ca and CC groups showed significant in-
crease (p < 0.05) in dLS/BS compared to the sham group.
For mineral appositional rate parameter (MAR), the Ca
and CC groups showed a significant increase (p < 0.05)
compared to the sham and OVX group.
The results for the cellular parameters are shown in
Table 2. The osteoblast surface (Ob.S/BS) of the Ca and
CC groups were increased significantly (p < 0.05) com-
pared to the OVX group. Osteoid volume (OV/BS) was
significantly increased (p < 0.05) in the sham and CC
groups compared to the OVX group. In addition, osteoid
volume of CC group was also higher (p < 0.05) compared
to the Ca group. No significant differences were seen in
the other parameters.
Discussion
Ovariectomy caused a state of estrogen deficiency which
may lead to bone loss. The use of rats as a model for
postmenopausal osteoporosis has been discussed and
significant bone loss may be seen as early as 14 days in
the proximal tibial metaphysis [21]. The ovariectomy-
a) Sham group b) OVX group
c) Ca group d) CC group
s LS
d LS 
Figure 1 Photomicrographs of trabecular bone labelled with calcein. Arrows indicating dLS (double-labeled surface) and sLS
(single-labeled surface).
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etal responses in post-menopausal women [22].
In this study, the ovariectomized group did not differ
to sham-operated group in terms of dynamic histomor-
phometry parameters (Table 1). These findings were in
agreement with our previous study except in one param-
eter. The previous study showed that the ovariectomized
rats had lower mineral appositional rate compared to
the sham-operated group [23]. In terms of cellular histo-
morphometry parameters, ovariectomy caused reduction
in osteoid volume as compared to the sham group.
Other parameters were not significantly different com-
pared to sham even though declining values were ob-
served. However, in another study it was observed that
cellular parameters deteriorated in the ovariectomizedTable 1 The effects of Cosmos caudatus and calcium on dynam
Dynamic parameters Sham
Single labeled surface (%) 75.44 ± 4.00
Double-labeled surface (%) 18.5 ± 3.33
Mineralized surface (%) 58.69 ± 1.10
Mineral appositional rate (μm/day) 1.52 ± 0.12
Bone formation rate (μm3/μm2/day) 1.00 ± 0.09
Sham sham-operated rats.
OVX ovariectomized rats.
Ca ovariectomized rats supplemented with 1% calcium.
CC ovariectomized rats supplemented with 500 mg/kg Cosmos caudatus.
* significant vs sham group (p < 0.05).
# significant vs OVX group (p < 0.05).
Data is presented as mean ± S.E.M.group as compared to the sham group [24]. The discrep-
ancies seen in the histomorphometry parameters be-
tween ovariectomized and sham-operated groups were
surprising and it may be attributed to the small sample
size used in our study. In addition, the technique used in
measuring the histomorphometric parameters may not
be sensitive since others have found that the use of
high-throughput technique such as microcomputed to-
mography was able to yield more significant results [25].
The effects of C. caudatus on bone biochemical
markers were previously investigated in which we used
the doses of 100, 200 and 300 mg/kg. It was observed
that all doses of C. caudatus were able to prevent the in-
crease in interleukin-1 and pyridinoline in the ovariecto-
mized group. However, no significant changes were seenic histomorphometry parameters in ovariectomized rats
OVX Ca CC
78.99 ± 3.35 73.8 ± 6.33 73.1 ±6 .33
24.68 ± 5.08 28.38 ± 2.78* 38.9 ± 4.10*
63.78 ± 1.18 60.55 ± 2.86 63.55 ± 3.10
1.52 ± 0.13 3.20 ± 0.38#* 3.60 ± 0.09#*
1.08 ± 0.02 1.58 ± 0.27 1.48 ± 0.29
Table 2 The effects of Cosmos caudatus and calcium on cellular histomorphometry parameters in ovariectomized rats
Cellular parameters Sham OVX Ca CC
Osteoblast surface (%) 30.92 ± 8.78 8.75 ± 5.15* 55.32 ± 10.2# 70.4 ± 7.78#
Osteoclast surface (%) 52.43 ± 12.59 65.56 ± 13.04 62.96 ± 6.68 36.12 ± 1.11
Eroded surface (%) 12.32 ± 6.00 38.89 ± 14.70 36.53 ± 9.15 22.62 ± 4.66
Osteoid volume (%) 13.13 ± 1.92 4.54 ± 2.46* 8.66 ± 1.07 18.27 ± 0.53#@
Osteoid surface (%) 72.95 ± 2.66 51.29 ± 3.43 63.08 ± 5.62 71.85 ± 7.09
Sham sham-operated rats.
OVX ovariectomized rats.
Ca ovariectomized rats supplemented with 1% calcium.
CC ovariectomized rats supplemented with 500 mg/kg Cosmos caudatus.
* significant vs sham group (p < 0.05).
# significant vs OVX group (p < 0.05).
@ significant vs Ca 1% (p < 0.05).
Data is presented as mean ± S.E.M.
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Following that, we proceeded with a higher dose i.e.
500 mg/kg and look at the bone histomorphometry
paramaters. Parts of the results from this study were
previously published in which we observed C. caudatus
was able to improve some of the structural bone
histomorphometry parameters as compared to ovariec-
tomized group [1]. In this article, we reported the
remaining half of the findings i.e. the dynamic and cellu-
lar bone histomorphometry parameters.
No significant differences were observed in single-
labeled surface between the treatment groups. High
single-labeled surface reflects high bone resorption rate
[26]. Thus, the absence of significant differences in this
parameter indicates that Ca 1% and C. caudatus did
not affect the resorption process. However, this study
showed that groups treated with Ca 1% and C. caudatus
had higher double-labeled surface. The presence of high
double-labeled surface indicates high bone formation and
active mineralization process [27,28]. The results sug-
gested that 500 mg/kg C. caudatus extract may play a
role in stimulating bone formation in ovariectomized
rats. Calcium, on the other hand, has been used as a
treatment for osteoporosis [29]. Daily calcium supple-
mentation has been shown to prevent bone loss in post-
menopausal women [30].
Mineral appositional rate (MAR) is the distance be-
tween two fluorescence labels which were formed when
calcein was injected on the ninth day and second day be-
fore rats were sacrificed [31]. MAR represents the osteo-
blastic activities in the bone [32]. High MAR value in
the Ca and CC groups is suggestive of high osteoblastic
activity. This is in agreement with osteoblast surface
value which was higher in the Ca and CC groups com-
pared to OVX.
Osteoid volume (OV/BV) was found to increase sig-
nificantly in the sham and CC groups compared to the
OVX group. The CC group also had a higher osteoidvolume compared to the Ca group. Osteoid is bone
matrix that is not mineralized yet. The increase in oste-
oid volume may occur due to the increase in osteoid for-
mation or by the disruption that has occurred during
the process of mineralization of bone [33]. The increase
in osteoid volume in the CC group showed that C.
caudatus may have a role in osteoid formation. This ef-
fect of C. caudatus is an advantage over Ca 1%. Cosmos
caudatus was found to have high phenolic content of
the flavonoids class (which include catechin, epicatechin,
myricetin and luteolin) and was observed to possess
free-radicals scavenging activity [34]. These properties of
C. caudatus may also contribute to its bone-protective
effects. It is also reported that C. caudatus contains
270 mg calcium per 100 g of the plant [35]. This com-
position, in addition to its antioxidative property, may
contribute to the superiority of C. caudatus as opposed
to calcium supplementation.
Calcium supplementation in this study was given in
drinking water at the concentration of 1%. This method
of administration was used in our previous study [36]
and has also been used by others [37]. The advantage of
using this route of administration is that it minimizes
the stress from using injection or oral gavage. However
we did not measure serum levels of calcium to ensure
adequate calcium intake which can further verify the dif-
ferences seen between the C. caudatus group and the Ca
1% group.
No significant differences in osteoid surface (OS/BS)
were observed between all the groups. Although the per-
centage of osteoid surface is higher in the Ca and CC
groups than in the OVX group, significant difference
was not observed. This may be attributed to the small
sample size used in this study.
There were no significant differences in osteoclast sur-
face (Oc.S/BS) between all the groups. However, based
on a previous study, there was a significant increase in
Oc.S/BS for ovariectomized rats [38]. In addition, post-
menopausal condition can stimulate the formation of
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(RANKL) and tumor necrosis factor (TNF) by mono-
cytes and T cell, and this phenomenon tends to occur in
women with osteoporosis [39]. C. caudatus did not seem
to cause any effects on osteoclast surface which implies
C. caudatus has no effects on resorption process.
Conclusions
C. caudatus has beneficial effects on dynamic and celluar
bone histomorphometry parameters in ovariectomized
rats. C. caudatus was also observed to be superior to Ca
1% in increasing the osteoid volume parameter. Thus, C.
caudatus has the potential to become an alternative
treatment in restoring bone damage in post-menopausal
women.
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